Discover how to efficiently produce wild-type or recombinant viruses to be used as vaccines and human gene therapy vectors. Learn more about results achieved for the production of AAV and a paramyxovirus in the Integrity® iCELLis® bioreactor developed by ATMI LifeSciences. These results indicated titer for AAV of 5.108 vg/cm² in the small scale iCELLis (versus 3.108 vg/cm² in 5-layer stack) and 0.5-1 log titer for paramyxovirus (versus tissue culture flask). Results of transient transfection processes showed similar transfection levels in iCELLis than in the stack.
- Using Validated Technology to Increase Assurance of Integrity and Sterility of Single-use Assemblies Immediately Before Use
- Virus Production: From Bench to Industrial Scale
- How to Industrialize Stem Cell Culture Processes?
- Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment